AG
Anastasios Gianakakos
President and CEODirector

Anastasios Gianakakos insider trades: MyoKardia (MYOK) stock buys and sales

President and CEO, MyoKardia Last trade Jul 2, 2020 118 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
93
Open-market trades
since 2008
4
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Anastasios reports to the SEC

Open-market buys and sales

93 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 2, 2020MYOK↓ Sell$470K
Jun 2, 2020MYOK↓ Sell$514K
May 18, 2020MYOK↓ Sell$1.3M
May 11, 2020MYOK↓ Sell$2.5M
May 4, 2020MYOK↓ Sell$292K
Apr 16, 2020MYOK↓ Sell$55K
Apr 8, 2020MYOK↓ Sell$75K
Apr 2, 2020MYOK↓ Sell$112K
Mar 2, 2020MYOK↓ Sell$322K
Feb 3, 2020MYOK↓ Sell$347K
Jan 14, 2020MYOK↓ Sell$377K
Jan 6, 2020MYOK↓ Sell$868K
Jan 3, 2020MYOK↓ Sell$359K
Dec 2, 2019MYOK↓ Sell$325K
Nov 4, 2019MYOK↓ Sell$295K
Oct 3, 2019MYOK↓ Sell$264K
Sep 11, 2019MYOK↓ Sell$55K
Sep 3, 2019MYOK↓ Sell$209K
Aug 8, 2019MYOK↓ Sell$55K
Aug 2, 2019MYOK↓ Sell$213K
Jul 22, 2019MYOK↓ Sell$55K
Jul 5, 2019MYOK↓ Sell$199K
Jan 7, 2019MYOK↓ Sell$122K
Jan 4, 2019MYOK↑ Buy$100K
Dec 12, 2018MYOK↓ Sell$167K
Nov 5, 2018MYOK↓ Sell$170K
Oct 4, 2018MYOK↓ Sell$175K
Sep 4, 2018MYOK↓ Sell$178K
Aug 6, 2018MYOK↓ Sell$172K
Jul 5, 2018MYOK↓ Sell$159K
Jun 4, 2018MYOK↓ Sell$141K
May 4, 2018MYOK↓ Sell$143K
Apr 4, 2018MYOK↓ Sell$144K
Mar 5, 2018MYOK↓ Sell$183K
Feb 26, 2018MYOK↓ Sell$300K
Feb 5, 2018MYOK↓ Sell$153K
Jan 12, 2018MYOK↓ Sell$250K
Jan 4, 2018MYOK↓ Sell$125K
Dec 21, 2017MYOK↓ Sell$123K
Nov 6, 2017MYOK↓ Sell$173K
Oct 4, 2017MYOK↓ Sell$176K
Sep 5, 2017MYOK↓ Sell$185K
Aug 4, 2017MYOK↓ Sell$71K
Jul 25, 2017MYOK↓ Sell$495K
Mar 20, 2017MYOK↓ Sell$21K
Apr 29, 2016MYOK↑ Buy$19K
Nov 3, 2015MYOK↑ Buy$14K
Feb 28, 2013MAPP↓ Sell$500K
Jan 23, 2013MAPP↓ Sell$743K
Nov 1, 2012MAPP↓ Sell$90K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Anastasios Gianakakos's insider trades

Anastasios Gianakakos is President and CEO at MyoKardia (MYOK). Since May 15, 2008, Anastasios has reported 3 open-market purchases worth $133K and 90 sales worth $16.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (72 filings), grants and awards (21 filings), shares withheld for taxes (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.